What is the treatment of threshold ROP:
**Core Concept**
Threshold Retinopathy of Prematurity (ROP) is a severe stage of ROP characterized by the presence of 5 contiguous or 8 non-contiguous clock hours of zone 1 plus disease, or any disease in zone 1 with plus disease in zone 2. The goal of treatment is to prevent progression to retinal detachment and vision loss.
**Why the Correct Answer is Right**
The treatment for threshold ROP is laser photocoagulation or anti-vascular endothelial growth factor (anti-VEGF) injections. Laser photocoagulation involves creating a barrier of retinal scarring to halt the progression of ROP by ablating the avascular retina and preventing further growth of abnormal blood vessels. Anti-VEGF injections, such as bevacizumab or ranibizumab, work by inhibiting the vascular endothelial growth factor (VEGF) pathway, which is crucial for the growth and survival of new blood vessels.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because retinal cryotherapy is not the standard treatment for threshold ROP. While cryotherapy can be used to treat peripheral retinal tears and detachments, it is not effective for treating ROP.
**Option B:** This option is incorrect because systemic corticosteroids are not the primary treatment for threshold ROP. Corticosteroids may be used to treat other complications of ROP, but they are not the standard treatment for threshold disease.
**Option C:** This option is incorrect because observation alone is not sufficient for threshold ROP. The disease has a high risk of progression to retinal detachment and vision loss, and active treatment is necessary to prevent this outcome.
**Clinical Pearl / High-Yield Fact**
Threshold ROP is a medical emergency that requires prompt treatment to prevent vision loss. The American Academy of Pediatrics and the American Academy of Ophthalmology recommend that infants with threshold ROP undergo treatment within 72 hours of diagnosis.
**Correct Answer:** C. Laser photocoagulation or anti-vascular endothelial growth factor (anti-VEGF) injections.